Metabolic syndrome, diabetes, poor cognition, and dementia in the caerphilly prospective study

Journal of Alzheimer's Disease

Volumn 28, Issue 4, 2012, Pages 931-939

  Creavin, Samuel T ^a   Gallacher, John ^b   Bayer, Antony ^c   Fish, Mark ^d   Ebrahim, Shah ^e   Ben Shlomo, Yoav ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Department of Primary Care and Public Health ^*  (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^d MUSGROVE PARK HOSPITAL   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Cognition disorders epidemiology; cohort studies; diabetes mellitus Type 2 complications; metabolic syndrome X epidemiology; risk factors

Indexed keywords

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NEUROPSYCHOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED KINGDOM;

EID: 84858029793     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111550     Document Type: Article

References (42)

1. Melzer D, Ely M, Brayne C (1997) Cognitive impairment in elderly people: Population based estimate of the future in England, Scotland, and Wales. BMJ 315, 462.
2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421.
3. Lawlor DA, Smith GD, Ebrahim S (2006) Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 49, 41-48.
4. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala EL, Haapala I, Nissinen A, Rauramaa R (2007) Metabolic syndrome and cognitive function:Apopulation-based follow-up study in elderly women. Dement Geriatr Cogn Disord 23, 29-34.
5. Ho RC, Niti M, Yap KB, Kua EH, Ng TP (2008) Metabolic syndrome and cognitive decline in Chinese older adults: Results from the Singapore longitudinal ageing studies. Am J Geriatr Psychiatry 16, 519-522.
6. Lee KS, Eom JS, Cheong HK, Oh BH, Hong CH (2010) Effects of head circumference and metabolic syndrome on cognitive decline. Gerontology 56, 32-38.
7. Kalmijn S, Foley D, White L, Burchfiel CM, Curb JD, Petrovitch H, Ross GW, Havlik RJ, Launer LJ (2000) Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 20, 2255-2260.
8. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA (2007) Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 24, 185-192.
9. Forti P, Pisacane N, Rietti E, Lucicesare A, Olivelli V, Mariani E, Mecocci P, Ravaglia G (2010) Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc 58, 487-492.
10. van den Berg E, Biessels GJ, de Craen AJ, Gussekloo J, Westendorp RG (2007) The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 69, 979-985.
11. Gale EA (2008) Should we dump the metabolic syndrome? Yes. BMJ 336, 640.
12. Akbaraly TN, Kivimaki M, Shipley MJ, Tabak AG, Jokela M, Virtanen M, Marmot MG, Ferrie JE, Singh-Manoux A (2010) Metabolic syndrome over 10 years and cognitive functioning in late midlife: The Whitehall II study. Diabetes Care 33, 84-89.
13. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56, 1113-1132.
14. Booth GL, Kapral MK, Fung K, Tu JV (2006) Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 29, 32-37.
15. Raffaitin C, Gin H, Empana JP, Helmer C, Berr C, Tzourio C, Portet F, Dartigues JF, Alperovitch A, Barberger-Gateau P (2009) Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: The Three-City Study. Diabetes Care 32, 169-174.
16. Chalmers J, Cooper ME (2008) UKPDS and the legacy effect. N Engl J Med 359, 1618-1620.
17. The Caerphilly, and, Speedwell Collaborative Group (1984) Caerphilly and Speedwell collaborative heart disease studies. J Epidemiol Community Health 38, 259-262.
18. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149, 698-709.
19. O'Carroll RE, Baikie EM, Whittick JE (1987) Does the National Adult Reading Test hold in dementia? Br J Clin Psychol 26(Pt 4), 315-316.
20. Nissen MJ, Bullemer P (1987) Attentional requirements of learning - evidence from performance-measures. Cogn Psychol 19, 1-32.
21. Heim AW (1970) A.H.4 group test of general intelligence manual, NFER Publishing Co. Ltd., Windsor (Berks.).
22. Gallacher JE, Pickering J, Elwood PC, Bayer AJ, Yarnell JW, Ben-Shlomo Y (2005) Glucoregulation has greater impact on cognitive performance than macro-vascular disease in men with type 2 diabetes: Data from the Caerphilly study. Eur J Epidemiol 20, 761-768.
23. Fish M, Bayer AJ, Gallacher JE, Bell T, Pickering J, Pedro S, Dunstan FD, Ben-Shlomo Y, Ebrahim S (2008) Prevalence and pattern of cognitive impairment in a community cohort of men in South Wales: Methodology and findings from the Caerphilly Prospective Study. Neuroepidemiology 30, 25-33.
24. American Psychiatric Association., American Psychiatric Association. Task Force on DSM-IV (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR, American Psychiatric Association, Washington, DC.
25. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260.
26. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
27. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15, 539-553.
28. Office for National Statistics, Current standard classifications, http://www.ons.gov.uk/ons/guide-method/classifications/current-standard- classifications/index.html, Accessed 28 February 2011
29. Symons MJ, Moore DT (2002) Hazard rate ratio and prospective epidemiological studies. J Clin Epidemiol 55, 893-899.
30. Gallacher J, Bayer A, Fish M, Pickering J, Pedro S, Dunstan F, Ebrahim S, Ben-Shlomo Y (2009) Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study. Psychosom Med 71, 659-666.
31. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292, 2237-2242.
32. Bonaldi C, Vernay M, Roudier C, Salanave B, Oleko A, Malon A, Castetbon K, Fagot-Campagna A (2011) A first national prevalence estimate of diagnosed and undiagnosed diabetes in France in 18- to 74-year-old individuals: The French Nutrition and Health Survey 2006/2007. Diabet Med 28, 583-589.
33. Millan-Calenti JC, Tubio J, Pita-Fernandez S, Gonzalez-Abraldes I, Lorenzo T, Maseda A (2009) Prevalence of cognitive impairment: Effects of level of education, age, sex and associated factors. Dement Geriatr Cogn Disord 28, 455-460.
34. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW (2007) Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 30, 2655-2660.
35. van den Berg E, Dekker JM, Nijpels G, Kessels RP, Kappelle LJ, de Haan EH, Heine RJ, Stehouwer CD, Biessels GJ (2008) Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: The Hoorn study. Dement Geriatr Cogn Disord 26, 261-269.
36. Qiu C, Winblad B, Fratiglioni L (2005) The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4, 487-499.
37. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N (2007) Metabolic syndrome and cognitive decline in elderly Latinos: Findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 55, 758-762.
38. Guan JW, Huang CQ, Li YH, Wan CM, You C, Wang ZR, Liu YY, Liu QX (2011) No association between hypertension and risk for Alzheimer's disease: A meta-analysis of longitudinal studies. J Alzheimers Dis 27, 799-807.
39. Staessen JA, Thijs L, Richart T, Odili AN, Birkenhager WH (2011) Placebo-controlled trials of blood pressure-lowering therapies for primary prevention of dementia. Hypertension 57, e6-e7.
40. Yaffe K, Weston AL, Blackwell T, Krueger KA (2009) The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 66, 324-328.
41. Alberti KG, Zimmet PZ (2008) Should we dump the metabolic syndrome? BMJ 336, 641.
42. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374, 1677-1686.